Figure 1.
Impact of HLA mismatch in the GVH vector. Comparison of overall survival (A) and the incidence of grade III to IV acute GVHD (B) after serologically one-locus–mismatched HSCT between patient-donor pairs with or without an HLA mismatch in the GVH vector.